Literature DB >> 11326663

CYFRA 21-1, TPA-M, TPS, SCC-Ag and CEA in patients with squamous cell lung cancer and in chemical industry workers as a reference group.

J Kulpa1, E Wójcik, A Radkowski, L Kolodziejski, Z Stasik.   

Abstract

In etiology of lung cancer chemical carcinogenesis seems to be a very important factor. In the studies presented here the diagnostic usefulness of tumor markers in lung cancer was evaluated, using as a reference group workers of a chemical plant producing chromite and chromate pigments. The investigations of CYFRA 21-1, TPA-M, TPS, CEA and SCC-Ag were performed before treatment in a group of 76 squamous cell lung cancer patients in different stages of disease and in a reference group of 75 workers of the chemical company, who had been exposed to hexavalent chromium for longer than 1 year and had no clinical or radiological symptoms of lung diseases. In the squamous cell lung cancer group concentrations of all analyzed tumor markers were considered to be significantly higher than in the reference group. TPA assay demonstrated higher diagnostic performance than CYFRA 21-1 and the remaining tumor markers. At 0.95 specificity, the sensitivity of TPA was 0.79, CYFRA 21-1 -0.76, of TPS -0.29 whilst of CEA and SCC-Ag -0.31. The univariate analysis showed a significant prognostic value for clinical stages, only for CYFRA 21-1 and SCC-Ag. A significant relationship between marker level and survival was observed for CYFRA 21-1 as well as SCC-Ag levels. In a multivariate analysis CYFRA 21-1 and/or TPS remained significant predictors of survival.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11326663

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  4 in total

Review 1.  Update on biomarkers for the detection of lung cancer.

Authors:  Eloisa Jantus-Lewintre; Marta Usó; Elena Sanmartín; Carlos Camps
Journal:  Lung Cancer (Auckl)       Date:  2012-06-11

2.  Functional screen for secreted proteins by monoclonal antibody library and identification of Mac-2 Binding protein (Mac-2BP) as a potential therapeutic target and biomarker for lung cancer.

Authors:  Lichao Sun; Lizhao Chen; Lixin Sun; Jian Pan; Long Yu; LuLu Han; Zhihua Yang; Yuanming Luo; Yuliang Ran
Journal:  Mol Cell Proteomics       Date:  2012-11-26       Impact factor: 5.911

Review 3.  The diagnostic accuracy of HE4 in lung cancer: a meta-analysis.

Authors:  Daye Cheng; Ying Sun; Hu He
Journal:  Dis Markers       Date:  2015-03-19       Impact factor: 3.434

4.  Serum thrombospondin-2 is a candidate diagnosis biomarker for early non-small-cell lung cancer.

Authors:  Yi-Ming Jiang; Dan-Lu Yu; Guo-Xin Hou; Jia-Lu Jiang; Qiang Zhou; Xiao-Fang Xu
Journal:  Biosci Rep       Date:  2019-07-25       Impact factor: 3.840

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.